ReShape Lifesciences Inc. (RSLS)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

4.52

-4.44%

After-hours Dec 13, 2024, 04:12 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04	FY03
Revenue	8.68M	11.24M	13.60M	11.30M	15.09M	606.71K	1.29M	786.66K	292.00K	-	-	312.00K	-	-	-	-	-	-	-	-	-
Cost of Revenue	3.13M	4.44M	5.25M	5.04M	5.78M	164.30K	936.39K	431.48K	125.00K	-	-	232.00K	-	-	-	-	-	-	-	-	-
Gross Profit	5.55M	6.80M	8.35M	6.26M	9.30M	442.41K	350.77K	355.18K	167.00K	-	-	80.00K	-	-	-	-	-	-	-	-	-
Operating Income	-14.64M	-27.08M	-27.75M	-12.46M	-15.89M	-38.55M	-31.41M	-22.80M	-27.87M	-25.59M	-24.73M	-22.55M	-25.26M	-16.18M	-24.21M	-36.27M	-28.03M	-18.12M	-11.15M	-3.45M	-1.90M
Interest Income	-	113.00K	832.00K	2.05M	451.00K	-	1.07K	5.84K	1.82K	3.33K	5.72K	9.88K	12.24K	5.60K	79.36K	1.10M	1.56M	1.14M	109.88K	-	-
Pretax Income	-11.34M	-46.59M	-62.04M	-21.81M	-75.10M	-38.71M	-36.13M	-23.36M	-25.50M	-26.13M	-25.78M	-23.46M	-25.29M	-17.35M	-31.93M	-36.29M	-28.48M	-18.12M	-11.14M	-	-
Net Income	-11.39M	-46.21M	-61.93M	-21.63M	-74.21M	-81.15M	-33.82M	-23.36M	-25.50M	-26.13M	-25.78M	-23.46M	-26.00M	-17.35M	-31.93M	-37.87M	-28.58M	-17.69M	-11.22M	-3.45M	-1.90M
Selling & General & Admin	17.87M	31.34M	33.58M	15.22M	22.07M	19.26M	25.98M	17.98M	19.89M	14.56M	13.66M	11.96M	8.58M	7.68M	8.63M	8.60M	6.97M	3.76M	2.32M	-	-
Research & Development	2.31M	2.54M	2.52M	3.50M	3.12M	5.72M	5.78M	5.17M	8.14M	11.03M	11.07M	10.67M	16.67M	8.50M	15.58M	27.67M	21.05M	14.36M	8.83M	-	-
Other Expenses	-	11.00K	23.50M	306.00K	-1.34M	-10.64K	-652	-	-	-	-	-	-	-	-	-	-	-	-	-3.45M	-1.90M
Operating Expenses	20.19M	33.88M	36.10M	18.72M	25.19M	24.98M	31.76M	23.15M	28.03M	25.59M	24.73M	22.63M	25.26M	16.18M	24.21M	36.27M	28.03M	18.12M	11.15M	-3.45M	-1.90M
Interest Expense	-	113.00K	832.00K	2.05M	451.00K	12.38K	3.87K	4.10M	939.18K	530.22K	932.36K	901.84K	722.86K	1.26M	4.10M	2.68M	1.65M	710.11K	181.15K	-	-
Selling & Marketing Expenses	7.55M	14.09M	9.16M	4.69M	4.85M	5.24M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	23.32M	38.32M	41.35M	23.76M	30.98M	25.15M	32.70M	23.58M	28.16M	25.59M	24.73M	22.86M	25.26M	16.18M	24.21M	36.27M	28.03M	18.12M	11.15M	-3.45M	-1.90M
Income Tax	52.00K	-380.00K	-106.00K	-181.00K	-893.00K	-3.45M	-2.31M	3.96M	-2.56M	347.10K	872.37K	-226.99K	740.74K	794.24K	7.29M	1.60M	549.15K	-431.34K	62.91K	3.45M	1.90M
Shares Outstanding (Basic)	102.70K	7.32K	3.77K	1.35K	1.62K	218.81	192.14	48.53	191.98	-	-	13.63K	10.42K	2.90K	1.72K	5.81K	843.10	178.43	134.17	48.81	54.83
Shares Outstanding (Diluted)	102.70K	7.32K	3.77K	1.35K	1.62K	218.81	192.14	48.53	191.98	-	-	13.63K	10.42K	2.90K	1.72K	5.81K	843.10	178.43	134.17	48.81	54.83
EPS (Basic)	-110.88	-6.32K	-16.44K	-48.19K	-137.17K	-370.88K	-176.01K	-481.39K	-132.82K	-	-	-1.72K	-2.50K	-5.98K	-18.61K	-6.52K	-33.89K	-99.14K	-83.59K	-70.66K	-34.67K
EPS (Diluted)	-110.88	-6.32K	-16.44K	-48.19K	-137.17K	-370.88K	-176.01K	-481.39K	-132.82K	-	-	-1.72K	-2.50K	-5.98K	-18.61K	-6.52K	-33.89K	-99.14K	-83.59K	-70.66K	-34.67K
EBITDA	-14.48M	-24.93M	-60.62M	-18.09M	-17.22M	-36.97M	-34.39M	-19.50M	-27.68M	-25.40M	-24.56M	-22.32M	-24.92M	-15.01M	-16.50M	-35.74M	-26.58M	-18.03M	-11.02M	-3.45M	-1.90M
Depreciation & Amortization	154.00K	2.15M	1.97M	1.67M	894.00K	581.00K	330.00K	192.00K	188.61K	188.90K	174.63K	226.99K	303.97K	375.76K	424.35K	513.06K	992.37K	95.85K	143.23K	-	-